Search Results - "Castells, Lluis"

High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation.

Authors: Dopazo, Cristina Bilbao, Itxarone García, Sonia et al.

Source: CTS: Clinical & Translational Science. Jun2022, Vol. 15 Issue 6, p1544-1555. 12p.

Corrigendum to “Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study” [J Hepatol 2015;62:92–100].

Authors: Castells, Lluis Rimola, Antoni Manzardo, Christian et al.

Source: Journal of Hepatology. Mar2016, Vol. 64 Issue 3, p757-757. 1p.

Secondary syphilis with liver involvement in a liver transplant recipient.

Authors: Ferrándiz‐Pulido, Carla Ferrer, Berta Salcedo, Maria Teresa et al.

Source: Transplant Infectious Disease. Feb2021, Vol. 23 Issue 1, p1-6. 6p.

Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.

Authors: Lens, Sabela García‐Eliz, María Fernández, Inmaculada et al.

Source: Liver International. Nov2018, Vol. 38 Issue 11, p1940-1950. 11p. 1 Diagram, 4 Charts, 2 Graphs.

A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.

Authors: Margarit, Carlos Bilbao, Itxarone Castells, Lluis et al.

Source: Transplant International. Dec2005, Vol. 18 Issue 12, p1336-1345. 10p. 5 Charts, 1 Graph.

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

Authors: Mariño, Zoe Pascasio‐Acevedo, Juan M. Gallego, Adolfo et al.

Source: Liver International. Dec2017, Vol. 37 Issue 12, p1823-1832. 10p. 1 Diagram, 3 Charts, 2 Graphs.

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease.

Authors: Young, Jim Weis, Nina Hofer, Harald et al.

Source: BMC Infectious Diseases. 1/7/2017, Vol. 17, p1-8. 8p. 1 Diagram, 4 Charts.

A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.

Authors: Pose, Elisa Torrents, Abiguei Reverter, Enric et al.

Source: Journal of Hepatology. Aug2021, Vol. 75 Issue 2, p275-283. 9p.

Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure.

Authors: Quintero, Jesús Miserachs, Mar Ortega, Juan et al.

Source: Liver International. May2014, Vol. 34 Issue 5, p689-694. 6p.

Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study.

Authors: Dopazo, Cristina Rodriguez, Roberto Llado, Laura et al.

Source: Clinical Transplantation. Jan/Feb2012, Vol. 26 Issue 1, pE32-E37. 6p. 2 Charts, 3 Graphs.

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.

Authors: Colmenero, Jordi Rodríguez-Perálvarez, Manuel Salcedo, Magdalena et al.

Source: Journal of Hepatology. Jan2021, Vol. 74 Issue 1, p148-155. 8p.

SAT-157 Identification of sarcopenia in patients with liver cirrhosis by combining anthropometry and ultrasound of thigh and psoas.

Authors: Campos-Varela, Isabel Céspedes, Carlos Palacio, Ester et al.

Source: Journal of Hepatology. 2025 Supplement 1, Vol. 82, pS195-S195. 1p.

Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients – a long-term prospective study.

Authors: Quintero, Jesús Juampérez, Javier Ortega, Juan et al.

Source: Transplant International. Jan2018, Vol. 31 Issue 1, p38-44. 7p. 2 Charts, 2 Graphs.

Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.

Authors: Pascasio, Juan Manuel Vinaixa, Carmen Ferrer, María Teresa et al.

Source: Journal of Hepatology. Dec2017, Vol. 67 Issue 6, p1168-1176. 9p.

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.

Authors: Fernández, Inmaculada Muñoz-Gómez, Raquel Hernández, Olga et al.

Source: Journal of Hepatology. Apr2017, Vol. 66 Issue 4, p718-723. 6p.

Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics

Authors: Varela, María Real, María Isabel Burrel, Marta et al.

Source: Journal of Hepatology. Mar2007, Vol. 46 Issue 3, p474-481. 8p.

THU417 - Impact of the universal access to direct-acting antivirals in the profile of hepatitis C treated patients.

Authors: Llaneras, Jordi Barciela, Mar Riveiro Pericas, Eulalia et al.

Source: Journal of Hepatology. 2020 Supplement 1, Vol. 73, pS344-S345. 2p.

THU284 - Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients.

Authors: Rodríguez-Tajes, Sergio Eliz, María García Caballero, Arantxa et al.

Source: Journal of Hepatology. 2020 Supplement 1, Vol. 73, pS278-S279. 2p.

THU072 - Delisting of liver transplant candidates after improvement in alcohol-related decompensated cirrhosis: a multicentric study on incidence and outcomes.

Authors: Pose, Elisa Torrents, Abiguei Perez-Campuzano, Valeria et al.

Source: Journal of Hepatology. 2020 Supplement 1, Vol. 73, pS176-S176. 1p.

Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.

Authors: Sort, Pau Navasa, Miquel Arroyo, Vicente et al.

Source: New England Journal of Medicine. 08/05/99, Vol. 341 Issue 6, p403-409. 1p.